Hepatic microsomal enzymes situated in the smooth endoplasmic reticulum of the liver cell are concerned with detoxication of many drugs and other foreign chemicals which enter the body, as well as the metabolism of some endogenous compounds such as corticosteroids. Stimulation of the activities of these enzymes may occur as a result of treatment with many therapeutic agents, such as phenobarbitone and phenylbutazone, and this process is known as enzyme induction. Many compounds present in the environment have enzyme-inducing properties, examples being aromatic hydrocarbons, some food additives and some insecticides (Conney 1967) . Enzyme induction may be regarded as a beneficial adaptive response, and the enhanced detoxication and elimination of foreign compounds which result facilitate survival in a chemically hostile environment. However, chronic exposure to enzymeinducing agents may lead to severe metabolic abnormalities, such as osteomalacia as a result of diversion of vitamin D metabolism to biologically inactive metabolites (Stamp et al. 1972) . Many carcinogens and some hepatotoxins exert their toxic effects via metabolites, and enzyme induction potentiates the activation of these compounds and therefore their toxicity (Udenfriend 1971 , Seawright et al. 1968 ).
We have used the urinary excretion of Dglucaric acid as a screening test for enzyme induction in the investigation of such problems. Excretion of this compound, which is formed via the glucuronic acid pathway in the liver, increases in epileptics treated with enzyme-inducing anticonvulsants, and correlates well with evidence of disordered calcium and folic acid metabolism in these subjects . Environmental exposure to DDT and other insecticides with enzyme-inducing properties causes urinary D-glucaric acid excretion to rise, as does the increased output of endogenous progestogens during normal human pregnancy (Davis et al. 1973) . Urinary D-glucaric acid excretion in animals correlates well with hepatic microsomal enzyme activity measured in vitro (Hunter et al. 1973) , and studies in human volunteers have shown that urinary D-glucaric acid excretion predicts increased rates of drug metabolism in groups of subjects . Estimation of urinary D-glucaric acid is simple and involves only a 24-hour urine collection on the part of the subjects under investigation, so for screening groups at risk for enzyme induction it offers distinct advantages.
